HOFV - MESO SSL among premarket losers

October, 02 2020 08:15 AM Hall of Fame Resort & Entertainment Company

Mesoblast (MESO) -37% after FDA rejects cell therapy application for treatment-resistant graft-vs-host disease.Benitec Biopharma (BNTC) -26%.Greenpro Capital (GRNQ) -18%.Tuniu (TOUR) -14%.Hall of Fame Resort & Entertainment (HOFV) -13%.Iterum Therapeutics (ITRM) -12%.Oxbridge Re Holdings (OXBR) -10%.GEE Group (JOB) -9%.Nano Dimension (NNDM) -9%.SelectQuote (SLQT) -9%.Sasol (SSL) -9% after forming joint venture with LyondellBasell.Westport Fuel Systems (WPRT) -9%.Evogene (EVGN) -10%.DiamondPeak Holdings (DPHC) -8%.CBAK Energy Technology (CBAT) -9%.Neurotrope (NTRP) -7%.Enlivex Therapeutics (ENLV) -8%.Ameri Holdings (AMRH) -8%.Hycroft Mining Holding (HYMC) -8% after pricing upsized units offering.Allena Pharmaceuticals (ALNA) -7%.Bloom Energy (BE) -7%.Forum Merger II (FMCI) -7%.The Chefs' Warehouse (CHEF) -7%.CleanSpark (CLSK) -7%.Boxlight (BOXL) -7%.SCWorx (WORX) -7%.SuRo Capital (SSSS) -7%.

For further details see:

MESO, SSL among premarket losers

Company Name:	Hall of Fame Resort & Entertainment Company
Stock Symbol:	HOFV
Market:	NASDAQ
Website:	hofreco.com

Twitter